In the news logo


It’s “In the News…” the only LIVE diabetes newscast! Our top stories this week: 100 years of insulin, the largest genetic study of type 1 diabetes is complete, approval for a new type 2 meds for teens, research moves forward on an insulin-producing implant and an Olympic hopeful starts a diabetes sports foundation!.
Watch “In the News…” live every Wednesday at 4:30pm EDT on the Diabetes Connections Facebook page

Check out Stacey’s book: The World’s Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here


Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcription below: 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  I’m on the road, so apologies if the audio and video are a little bit off but I think we’re good enough. And As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.


Lots of articles, op-eds and celebrations to mark this week’s 100th anniversary of the discovery of insulin. In July of 1921, the collaboration of Frederick Banting, Charles Best, James Collip and John Macleod led to the isolation and purification of insulin.

Most marking the occasion this year are focusing on access and affordability..

The International Diabetes Federation is launching a three year campaign to celebrate the advances made in diabetes, but also to call on more action to ensure all people living with diabetes have the best possible quality of life and health outcomes.



The largest and most diverse genetic study of type 1 diabetes ever undertaken is complete. Researchers at UVA say they’ve identified the “most likely causal genetic variants associated with risk and their target genes.” They hope the results will help lead to better medical and drug treatment or possible prevention and genetic treatments. This study looked at more than 60-thousand people. and identified 78 regions on our chromosomes where genes are located that influence our risk for Type 1 diabetes. Of those, 36 regions were previously unknown.


New partnership announced between LifeScan the glucose monitoring company and Noom, a digital health platform focused on behavior change.

LifeScan will be the first digital health diabetes management company to partner with  Noom’s Diabetes Support Program. The goal is to bring personalized health insights to better address eating habits and weight management.

The new fully-integrated OneTouch Solutions program will be available first to consumers in the US starting this Fall.


AstraZeneca gets approval for its once weekly diabetes medicine  Bydureon in kids as young as ten.


The injectable is used for people with type 2 diabetes. The approval comes about a month after data showed the drug significantly reduced blood glucose levels in adolescents compared to placebo. Bydureon is already approved for adults with type-2.

The only other non-insulin options available for adolescents with type 2 have to be taken daily.


Rice University bioengineers are using 3D printing and smart biomaterials to create an insulin-producing implant.

The three-year project is supported by a grant from JDRF. They researchers will use insulin-producing beta cells made from human stem cells to create an implant that senses and regulates blood glucose levels by responding with the correct amount of insulin at a given time.

The goal here is to show their implants can properly regulate blood glucose levels of diabetic mice for at least six months. So we’re really early on here but it’s an interesting new way of looking at reproducing what the pancreas does.


A judge rules that Roche did NOT infringe Insulet’s patent – this case brought over a patch pump sold in the UK. We told you about this case a few weeks back.. Insulet claimed because of it’s Omnipod patent, Roche didn’t have the right to sell it’s Accu Chek Solo. The judge ruled for Roche.


An Olympic hopeful with type 1 is sitting out the Tokyo games due to an injury.. but she’s also inspiring others and starting a new non profit to help other people with diabetes. Long jumper Kate Hall Harnden was on track for the 2020 Olympics, but was injured this past January

Diagnosed at age ten, she and her husband have formed the DiaStrong Foundation, which aims to give financial assistance to people with diabetes who want to improve in their sport and diabetes management.

They’ve planned to launch grants for financial assistance in July 2021, and those details are being finalized. They’ll host two camps in Maine this year.. one for teens and one for any age.

I’ve linked up to a great story in DiabetesMine if you want more info..


That’s In the News for this week.. if you like it, please share it!

And join me wherever you get podcasts for our next episode -Tuesday –  I’m talking to Omnipod – we’ll get a update on the Omnipod 5 with Horizon system. This week’s interview – the one that’s out right now – is with Gold Medal Olympian Gary Hall Jr – when he was diagnosed in 1999 he was told to give up swimming. He didn’t and he talks about why.. and how he overcame what was conventional wisdom for athletes at the time.

Thanks and I’ll see you soon

Leave a Reply